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Introduction 
Crohn’s disease (CD) and intestinal tuberculosis (ITB) are chronic diseases of the 
intestine. These diseases can present with similar clinical, radiologic, endoscopic and 
histopathologic findings.  Hence differentiating these diseases from one another can be 
difficult.  This affects the treatment.  In event of misdiagnosis, treating Crohn’s disease 
with anti tubercular drugs can result in the patient being exposed to the toxicity of these 
drugs as well as delay in treatment of Crohn’s disease.  On the other hand, treating a 
tuberculosis patient misdiagnosed as Crohn’s disease with steroids can result in flare up 
or dissemination of tuberculosis which can be disastrous.    These issues emphasize the  
 need for a definite diagnosis before the start of therapy.   
Two decades ago,  Crohn’s disease was rare in India while intestinal tuberculosis was 
common.  During the past decade, there has been an emergence of Crohn’s disease in 
India making differentiation of the two diseases an important issue[1].  Few studies have 
attempted to address this problem.  Patel et al after an exhaustive histological and 
microbiological evaluation for intestinal tuberculosis could make a definite diagnosis in 
only 66.5% of  patients [2].   Serological tests like  anti-neutrophil cytoplasmic antibody 
(ANCA) and anti-Saccharomyces Cerevisiae antibody (ASCA) were not found useful in 
differentiation of Crohn’s disease and intestinal tuberculosis [3, 4].  TB PCR was found 
highly specific for diagnosis of intestinal tuberculosis , but lacked sensitivity[5].  
There are a few reports which suggest that differentiation of Crohn’s disease from 
intestinal tuberculosis is possible on the basis of endoscopic [6] and histological 
characteristics [7-10].  Individual investigation results ( except presence of AFB or 
 7
caseating granulomas for tuberculosis ) are often found insufficient for diagnosis. There 
is therefore a need for a comprehensive study that can effectively differentiate intestinal 
tuberculosis from Crohn’s disease.  
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Aims. 
• To analyze clinical, laboratory, radiologic, endoscopic and histological characteristics of 
intestinal tuberculosis and Crohn’s disease and identify the parameters that differentiate 
the two diseases.   
• To devise and validate a scoring system to help differentiate Crohn’s disease from 
intestinal tuberculosis.  
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Review of literature 
Crohn’s disease (CD) and tuberculosis (TB) are granulomatous disorders of the intestinal 
tract with similar clinical presentation. Differentiation between the two poses a dilemma 
to clinicians and pathologists but is essential for appropriate management. An increasing 
incidence of Crohn’s disease in countries where tuberculosis continues to be highly 
prevalent  has heightened the necessity for a clearer understanding of how to differentiate 
the two diseases [8, 11, 12].  The advent of AIDS and increased global travel make this a 
dilemma faced by gastroenterologists and pathologists in Western countries as well[13, 
14]  .  
 
Changing epidemiology of intestinal tuberculosis and Crohn’s disease 
 
Although tuberculosis  remains a common problem in underprivileged areas of the world 
and less common in the developed world, the epidemiology  of the disease is changing. 
For example, in North America, an increase in the number of cases of tuberculosis has 
been observed since the mid-1980s mainly attributable to immigration, human 
immunodeficiency virus and the development of multidrug-resistant strains of 
tuberculosis [15] . At the same time, the incidence of Crohn’s disease  in areas that are 
endemic for tuberculosis  has increased. In a study from Saudi Arabia, the mean annual 
incidence of Crohn’s disease  over two decades changed from 0.32 / 100,000 to 1.66 / 
100,000, representing more than a fivefold increase [16] and a similar observation was 
found in the pediatric population from the same area [17]. In a Lebanese study conducted 
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over the period from 2000 to 2004, the mean annual incidence was 1.4 / 100,000 [18] . 
Similar findings were also observed in Iran, South Asia and South Africa[12, 19, 20] . 
The epidemiology of Crohn’s disease has changed over the years with increasing reports 
of Crohn’s disease affecting the pediatric population as well as adults. In India there is an 
increase in the number of Crohn’s disease cases reported [1] .  
 
Pathogenesis  
 
Intestinal tuberculosis  is caused by mycobacterium tuberculosis whereas Crohn’s disease 
has multifactorial etiology which includes genetic, immunological, environmental and 
microbial factors. Both trigger potent adaptive Th 1 cytokine responses which result in 
granuloma formation and are characterized by robust production of interferon gamma , IL 
12 and IL 23.  
 
The present evidence suggests that Crohn’s disease results from abnormal immune 
response to commensal gut bacteria in genetically predisposed individuals. Normally gut 
inflammation is kept in check through immune tolerance.  Tolerance is mediated in part 
by subsets of CD4+ helper T cells that are generated in the intestinal mucosa and secrete 
the down-regulatory cytokines, transforming growth factor (TGF)-β1 and interleukin  
(IL)-10.  Two specific T cell populations—T regulatory 1 (Tr1) and T helper 3 (Th3) 
cells—appear to have similar roles in maintaining mucosal tolerance in the intestine [21].  
Evidence points to an over-responsiveness of mucosal T cells to the enteric flora [22]  in 
Crohn’s disease. When an antigenic challenge occurs, or when tolerance is broken, the 
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immune response is skewed toward cell-mediated immunity via Th1 cell response.   Th 1 
response leads to elaboration of a variety of injurious and proinflammatory substances 
that cause tissue destruction and granuloma formation.  
 
The interaction between T cells and macrophages is critical to the pathogenesis of 
Crohn's disease. Both cell types are found together in the earliest lesions of Crohn's 
disease. The antigens that perpetuate the inflammatory response are taken up by 
macrophages. Degradation of antigen within proteosomes in macrophages results in 
presentation of an epitope in the context of the class II major histocompatibility complex 
(MHC). Interaction between MHC class II and the T cell receptor (CD3) results in 
antigen-specific interaction between the macrophage and the CD4+ T cell.  
 
The sustained nature of the immune response in Crohn’s disease may have diverse 
causes. Poor intestinal barrier function may permit continued exposure of lamina propria 
lymphocytes to antigenic stimuli from the lumen. Poor barrier function also may be a 
factor in the onset of Crohn's disease, because such patients have increased intestinal 
permeability preceding clinical relapse of disease [23].  Alternatively, a sustained 
exaggerated inflammatory reaction may result from an ineffective immune response—
resulting from a variety of defects—to an ever-present stimulus, as occurs in a number of 
conditions in humans in which there is a known immunologic defect. Finally, the 
sustained nature of the inflammation may result from a programmed over-
responsiveness to a persistent stimulus. 
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The principal cause of intestinal tuberculosis  is Mycobacterium tuberculosis. Intestinal 
tuberculosis  may be a primary infection, or secondary following reactivation, usually 
from a primary pulmonary focus.  Assumed routes of infection of the gastrointestinal 
tract are ingestion, for example, of bacilli in sputum from an active focus in the lung, 
haematogenous spread from the lung, from infected lymph nodes and direct spread from 
adjacent organs.  
 
Genetics 
 
The relative risk among first-degree relatives of Crohn’s disease  is 14 to 15 times higher 
than that of the general population [24]. The concordance rate among monozygotic twins 
is as high as 67% for Crohn's disease[25-27]  .  The presence of a locus on chromosome 
16 (the IBD1 locus) had been confirmed repeatedly to be linked to Crohn's disease, 
indicating the presence of a Crohn's disease gene in this region [27]. 
IBD1 locus has been identified as the NOD2 (nucleotide-binding oligomerization domain 
2) gene, also known as CARD15 (caspase-recruitment domain 15)[28, 29].  Persons with 
disease-associated allelic variants on both chromosomes have a 40-fold relative risk of 
Crohn's disease compared with those lacking variant NOD2/CARD15 genes, whereas 
heterozygous individuals have a sevenfold relative risk of Crohn's disease [29]. 
Nevertheless, the penetrance of NOD2/CARD15 is estimated to be less than 1% [30] ; 
that is, disease-related allelic variants of the gene may be found in a large number of 
individuals who do not have Crohn's disease. This strongly suggests that environmental 
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factors, as yet incompletely elucidated, play a significant role in the expression of the 
Crohn's disease phenotype. 
The OCTN (organic cation transporter) gene, located at IBD5 locus on chromosome 
5q31[31, 32]  and the  DLG5 gene , located on chromosome 10q23also have been 
associated with Crohn’s disease.   
In contrast to Crohn’s disease, the contributions of genetic mutations in intestinal 
tuberculosis have not been found.  
 
Pathology 
 
Focal intestinal inflammation is the hallmark pathologic finding in Crohn's disease.  
The earliest characteristic lesion of Crohn's disease is the aphthous ulcer. The presence 
of granulomas , although highly characteristic of Crohn's disease, is neither unique to 
Crohn's disease nor universally found.  Estimates of the prevalence of granulomas in 
Crohn's disease have varied greatly, ranging from 15% in endoscopic series [33] to as 
high as 70% in surgical series [34]. TNF is the key cytokine in the formation of 
granulomas. Appreciation of this fact led to the concept of anti-TNF therapies as a 
treatment for Crohn's disease.   In contrast with the granulomas of tuberculosis, there is 
little or no central necrosis. 
 When the disease becomes chronic, aphthae may coalesce into larger ulcers with a 
stellate appearance. Linear or serpiginous ulcers may form when multiple ulcers fuse in a 
longitudinal direction. With linear and transverse coalescence of ulcers, the classic 
cobblestone appearance may result, as networks of ulcers surround areas of relatively 
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normal mucosa with prominent submucosal edema. Ulcers also may extend down to the 
muscularis propria. 
Large ulcers, sinus tracts, and strictures are late features of Crohn’s disease. Sinuses and 
fistulas represent extensions of fissures; sinus tracts end blindly, and fistulas enter 
epithelial-lined organs such as bowel, skin, bladder, or vagina. 
With penetration of inflammation to the serosa, serositis may occur, resulting in adhesion 
of bowel to loops of small bowel, colon, or other adjacent organs. As a result of the 
chronicity of the inflammatory process, free perforation is much less common than 
walled-off perforation or contained intra-abdominal abscesses or fistula formation. 
Fibrosis is another transmural aspect of the disease. Fibrosis may be evident grossly as 
irregular thickening of the bowel wall and, along with hypertrophy of the muscularis 
mucosa, may contribute to the development of strictures. One of the most characteristic 
findings of Crohn’s disease is the presence of fat wrapping. This finding is highly 
characteristic of Crohn’s disease and is referred to as  “creeping” of mesenteric fat onto 
the serosal surface of the bowel. 
 
In  intestinal tuberculosis , the ileocaecal region is the most common site of involvement, 
although tuberculosis can have a focus at any site in the gastrointestinal tract, associated 
lymph nodes and/or peritoneum. Intestinal tuberculosis  usually has one of the three 
forms: ulcerative, hypertrophic or ulcerohypertrophic, and fibrous [35].  
Tuberculous granulomas initially form in the mucosa or Peyer’s patches, whereas ulcers 
are relatively superficial, with a different appearance from those in Crohn’s disease. 
Intestinal tuberculosis progresses slowly and presents late with complications, especially 
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acute or subacute obstruction due to mass (tuberculoma), stricture formation in the 
ileocaecal region or perforation leading to peritonitis. 
 
Clinical feaures 
 
Crohn's disease has a predilection for the distal small bowel and proximal large bowel. 
Nearly one half of all patients have disease affecting both ileum and colon. Another one 
third have disease confined to the small bowel, primarily the terminal ileum and in some 
cases including the jejunum as well [36]. From 20% to 25% of patients have disease 
confined to the colon. 
Abdominal pain is a frequent and persistent complaint. Pain may be intermittent and 
colicky or sustained and severe and is attributable to obstruction, inflammation or 
abscess. 
Constitutional symptoms, particularly weight loss and fever, or growth retardation in 
children, may be prominent and occasionally are the sole presenting features of Crohn's 
disease. 
Disease of the ileum, often accompanied by involvement of the cecum, may present 
insidiously. Some patients present with a small bowel obstruction, perhaps precipitated 
by impaction of indigestible foods such as raw vegetables or fruit. Many years of 
subclinical inflammation may progress to fibrotic stenosis, with the subsequent onset of 
intermittent colicky pain, sometimes accompanied by nausea and vomiting. 
Colonic disease may involve mainly the right colon or may extend distally to involve 
most or all of the colon (extensive or total colitis). In patients with Crohn's colitis, 
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tenesmus is a less frequent complaint than in patients with ulcerative colitis, because the 
rectum often is not involved or may be less severely inflamed than other colonic 
segments. The typical presenting symptom of colonic disease is diarrhea, occasionally 
with passage of obvious blood. The severity of the diarrhea tends to correlate with both 
the extent of colitis and the severity of inflammation, and the presentation may range 
from minimally altered bowel habits to fulminant colitis. Abdominal pain may be present 
to a greater extent than is seen in ulcerative colitis. Systemic manifestations such as 
weight loss and malaise also may be prominent. 
Perianal disease is another common presentation of Crohn's disease. In as many as 24% 
of patients with Crohn's disease, perianal disease precedes intestinal manifestations with 
a mean lead time of 4 years [37]. More often, however, perianal disease occurs 
concomitantly with or after the onset of the symptoms of luminal disease. Perianal 
findings may be categorized as skin lesions, anal canal lesions, and perianal fistulas [38]. 
 Skin lesions include maceration, superficial ulcers, and abscesses. Anal canal lesions 
include fissures, ulcers, and stenosis. The anal fissures of Crohn's disease tend to be 
placed more eccentrically than the usual idiopathic fissures, which generally occur in the 
midline.  
Upper gastrointestinal tract Crohn's disease is uncommon in the absence of disease 
beyond the ligament of Treitz. Approximately one third of patients with proximal Crohn's 
disease do not have evidence of distal Crohn's disease at the time of diagnosis, but 
virtually all develop distal disease in time [39]. 
Esophageal Crohn's disease is rare, occurring in less than 2% of patients. The presenting 
symptoms may include dysphagia, odynophagia, substernal chest pain, and heartburn. 
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These symptoms may be progressive and lead to profound weight loss [40]. Aphthous 
ulcers may sometimes be found in the mouth and posterior pharynx.  
Disease behavior in Crohn's disease may be divided roughly into two categories: 
aggressive fistulizing disease and indolent cicatrizing disease denoted by fibrostenotic 
stricture [41]; a third subset of patients appear to develop neither behavior over long 
periods of observation. Moreover, these categories of disease can overlap wth both fistula 
and stricture occurring  simultaneously in the same patient or at different times. 
Fistulas are frequent manifestations of the transmural nature of Crohn's disease. Immune 
activation triggers the release of a variety of proteases and matrix metalloproteinases 
[42] that may contribute directly to tissue destruction, sinus tract formation, and, finally, 
penetration to adjacent tissues. Perianal fistulas are common and are estimated to occur in 
15% to 35% of patients.  One fourth of all patients with Crohn's disease will present with 
an intra-abdominal abscess at some time in their lives [43]. 
The classic presentation of an intra-abdominal abscess is that of a patient with spiking 
fevers and focal abdominal tenderness or localized peritoneal signs. Unfortunately, many 
of the patients at highest risk for perforation or abscess also are on glucocorticoids, which 
are notorious for suppressing peritoneal signs and fever and masking the presentations of 
infection. Therefore, a high level of suspicion must be maintained.  
Stricture is another characteristic complication of Crohn's disease. Strictures represent 
long-standing inflammation and may occur in any segment of the gastrointestinal tract in 
which inflammation has been active. Strictures do not develop in all patients with 
inflammatory disease but are likely to recur, most often at the anastomosis, in patients 
who undergo bowel resection because of a stricture. One fourth of all patients with 
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Crohn's disease will have an extraintestinal manifestation of inflammatory bowel disease. 
[44].  
 
The clinical features of intestinal tuberulosis  are nonspecific. The predominant symptom 
is abdominal pain noted in upto 90% of cases.  .  Intestinal tuberculosis  patients often 
have fever, night sweats, anorexia , weight loss and diarrhea [45]. If the abdominal cavity 
is involved, there may be ascites.  Sometimes obstruction can lead to proximal bacterial 
overgrowth leading to malabsorption.  
In intestinal tuberculosis , all regions from the oesophagus to the rectum may be 
involved. Oesophageal tuberculosis is very uncommon and mimics oesophageal 
carcinoma. Gastroduodenal tuberculosis may mimic peptic ulcer disease or present with 
symptoms of pyloric obstruction, thus being confused with adenocarcinoma. Ileocaecal 
tuberculosis presents with abdominal pain, a right iliac fossa mass, altered bowel habits 
and bleeding, which mimics Crohn’s disease, carcinoma, amoebiasis, enteric fever or 
Yersinia enterocolitica. Colonic tuberculosis occurs in about 10% of cases, and may 
mimic carcinoma or, more  rarely, ulcerative colitis. In rectal tuberculosis the 
predominant symptom is bleeding, and in anal tuberculosis fistulae are common, both 
mimicking carcinoma or Crohn’s disease [46] .  
In children, the presenting features of intestinal tuberculosis  are similar with abdominal 
pain, fevers and ascites[47, 48]  .  Malnutrition is a common feature of intestinal 
tuberculosis  in children. Some cases may have a right iliac fossa mass.  The nonspecific 
laboratory abnormalities which can be seen are anemia, hypoalbuminemia and an 
elevated ESR.   
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Diagnosis 
 
A single gold standard for the diagnosis of Crohn’s disease is not available. The 
diagnosis is confirmed by clinical evaluation and a combination of endoscopic, 
histological, radiological, and/or biochemical investigations (ECCO consensus statement) 
[49].   Crohn’s disease is a heterogeneous entity comprising a variety of complex 
phenotypes[41, 50-52]   .   
Anemia, hypoalbuminemia, an elevated C-reactive protein or erythrocyte sedimentation 
rate, although not specific for IBD, may prompt further investigation.  As there is no 
single way to diagnose Crohn’s disease, Lennard-Jones et al have defined macroscopic 
and microscopic criteria to establish the diagnosis. The macroscopic features include 
physical examination, endoscopy, radiology, and examination of an operative specimen. 
Microscopic features can be only partly assessed on mucosal biopsy, but completely 
assessed on an operative specimen. The diagnosis depends on the finding of 
discontinuous and often granulomatous intestinal inflammation [53].  The current view is 
that the diagnosis is established by a nonstrictly defined combination of clinical 
presentation, endoscopic appearance, radiology, histology, surgical findings. 
A small bowel follow-through study is the primary modality to evaluate for small bowel 
disease.  Early findings include aphthous ulcers, a coarse villous pattern of the mucosa, 
and thickened folds. Submucosal edema may be evident as thickening or flattening of the 
valvulae conniventes, whereas transmural edema manifests as widening of the separation 
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between loops of bowel. Ulcers most often occur on the mesenteric border with 
consequent pseudosacculation of the antimesenteric border because of shortening of the 
mesenteric border [54].   Later findings include a cobblestone appearance resulting from 
edema in relatively spared islands of mucosa that are separated by longitudinal and 
transverse knife-like clefts of ulceration [54].  Still later, one may discern fistulas, sinus 
tracts, and fixed strictures. 
The features suggestive of Crohn’s disease on CT scan  of the abdomen are  mesenteric 
lymphadenopathy, transmural thickening of the bowel and   fibrofatty proliferation of the 
mesentery. CT is the investigation of choice  for identifying suppurative complications of 
Crohn's disease, such as intra-abdominal and retroperitoneal abscess 
Colonoscopy  shows aphthous ulcers, mucosal edema, cobblestoning. Discontinuous 
segmental nature of the disease and rectal spaing are characteristic  [55].  In a prospective 
endoscopic study of patients with Crohn’s disease who were about to start a course of 
prednisone, the incidence of endoscopic findings was as follows:superficial erosions, 
93%; deep erosions, 74%; mucosal edema, 48%; erythema, 44%; pseudopolyps, 41%; 
aphthous ulcers, 10%; ulcerated stenosis, 8%; and non-ulcerated stenosis, 2% [56].  In 
another study of 44 patients of Crohn’s disease , aphthous ulcers were seen in 81.8% ,  
cobble stone appearance in 34.1% , pseudopolyps in 27.3% , longitudinal ulcers in 
40.9%,  transverse ulcers in 25% [6].    
In Crohn’s disease granulomas can be found in histopathology-  they are usually sparse, 
scattered, not well formed with little or no central necrosis, and acid-fast stains for AFB 
and mycobacterial cultures are negative. Other features include   focal crypt 
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inflammation, focal areas of marked chronic inflammation, the presence of aphthae and 
ulcers on a background of little or no chronic inflammation, and the interspersing of 
segments of involved bowel with segments of uninvolved bowel. Transmural 
involvement and presence of lymphoid aggregates in both the submucosa and external to 
the muscularis propria are other suggestive features on biopsy. 
For diagnosing intestinal tuberculosis the  main diagnostic utilities are imaging, biopsy 
for histology and culture. Intestinal tuberculosis can be diagnosed if there is clinical, 
colonoscopic, and/or radiologic evidence of  intestinal tuberculosis with histologic 
demonstration of acid fast bacilli or growth of Mycobacterium  tuberculosis on tissue 
culture or histologic evidence of caseating granulomas or evidence of proved tuberculosis 
elsewhere [6]. 
An abdominal radiograph yields no specific information for identifying intestinal 
tuberculosis  but may reveal obstruction or perforation and calcified mesenteric lymph 
nodes. Barium studies are particularly useful in demonstrating mucosal lesions. The main 
imaging techniques are small bowel follow through and CT abdomen. The common 
imaging features that may be seen in intestinal tuberculosis are as follows: (1) enlarged 
para-aortic nodes, (2) asymmetric bowel wall thickening, (3) ascites, (4) inflammatory 
mass of bowel wall lymph nodes and omentum, (5) narrowing of the terminal ileum with 
thickening and gaping of the iliocaecal valve, (6) ‘white bowel’ sign due to lymphatic 
infiltration and (7) ‘sliced bread sign’ due to fluid surrounding bowel caused by 
inflammation of the bowel wall [46].  
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Colonoscopy shows nonspecific findings. In a study of intestinal tuberculosis patients the 
findings on colonoscopy were patulous ileocecal valve (40%), transverse ulcers (65.9%), 
longitudinal ulcers (2.3%), cobblestone appearance (6.8%), pesudopolyps (52.3%) [6]. 
 
The histopathologic features seen in intestinal tuberculosis are  chronic inflammation, 
ulceration, granulomas, caseation [9].  Other features such as cryptitis and crypt abscess 
may also be found.  Histopathologic sections may reveal acid fast bacilli which is specific 
for the diagnosis of tuberulosis.  
 
Differentiating Crohn’s disease from intestinal tuberculosis.  
 
Both intestinal tuberculosis and Crohn’s disease  are chronic granulomatous disorders 
[10] with similarities that make the differentiation between these two entities very 
difficult but at the same time crucial, as the repercussions of a misdiagnosis carry grave 
consequence. There have been reports of misdiagnosing intestinal tuberculosis as Crohn’s 
disease for as long as 7 years before the correct diagnosis was reached [57].  
Distinguishing Crohn’s disease from intestinal tuberculosis especially in highly endemic 
areas for tuberculosis  is challenging, and a diagnosis of Crohn’s diseae in individuals 
from such areas should be made after careful evaluation of all diagnostic modalities [58, 
59] . At the same time, it should not cause the clinicians to delay the diagnosis of Crohn’s 
disease, as this would delay definitive treatment of the disease.  
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Clinical Presentation 
 
The symptoms and signs of intestinal tuberculosis are nonspecific and may closely  
resemble Crohn’s disease. A high index of suspicion is required as otherwise the 
diagnosis may be missed or delayed, and the institution of immunosuppressive therapy 
would result in an increase in morbidity and mortality in patients with intestinal 
tuberculosis.  Most of the intestinal tuberculosis patients usually present with symptoms 
ranging from 1 month to 1 year. Pain is the most common presentation in about 85 % , 
weight loss in 66 % , fever in 35 – 50 % and diarrhea in only 20 % of patients [15] . On 
physical examination, abdominal tenderness is found in most patients and an abdominal 
mass, usually in the right lower quadrant, in 25 to 50 % of patients. A majority of these 
patients present with obstruction like symptoms or with fistulisation [60] and 
intussusception [61] but occasionally they may present with recurrent significant  
gastrointestinal tract blood loss [62] .Unusual presentations include bowel perforation 
and dysentery, and thus intestinal tuberculosis should always be considered in the 
differential diagnosis of unusual gastrointestinal presentations especially in highly 
endemic areas [63] . Furthermore, intestinal tuberculosis has been identified in 
asymptomatic patients who undergo colonoscopies for other reasons [64] . 
Some of the features on history and physical examination that favor the diagnosis of 
Crohn’s disease are younger age, oral ulcers, perianal disease, enteric fistulae and 
extraintestinal manifestations of Crohn’s disease[10, 65] , although intestinal tuberculosis 
involvement of the lower limb joints, skin, eye and liver may mimic extraintestinal 
Crohn’s disease[66, 67].  In addition, bleeding per rectum, diarrhea and shorter duration 
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of symptoms may favor Crohn’s disease rather than intestinal tuberculosis [68, 69].  
Fever is seen in both Crohn’s disease and intestinal tuberculosis, but a high swinging 
fever (>38.5 ° C) favors intestinal tuberculosis in the absence of any intra-abdominal 
abscess. Peritoneal involvement with ascites would also favour a diagnosis of intestinal 
tuberculosis but as it is often absent it is not very discriminatory [70] . 
 
Serological Tests And Cultures 
 
The laboratory diffeerentiation between intestinal tuberculosis and Crohn’s disease has 
not had great success. Routine routine blood tests looking at the cell counts and 
fractionation of white blood cells and other conventional tests, such as the erythrocyte 
sedimentation rate and C-reactive protein, are too nonspecific and do not aid in the work-
up of these patients. A recent series of studies showed that the use of different serological 
markers, such as the anti-neutrophil cytoplasmic antibodies, the peri-nuclear and the 
cytoplasmic variants (p-ANCA and c-ANCA), and the IgA and IgG subtypes of anti- 
Saccharomyces cerevisiae antibodies, had no significant diagnostic value[3, 4, 69] in 
discriminating between intestinal tuberculosis and Crohn’s disease. These tests should 
not therefore be relied upon for distinguishing intestinal tuberculosis from Crohn’s 
disease. 
 
The most reliable differentiation method is to find evidence of M. tuberculosis in the 
intestinal tissues. Unfortunately, acid-fast bacilli staining lacks sensitivity. In addition, 
the biopsy culture for M. tuberculosis is time consuming (3 – 8 weeks) and results are 
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frequently negative (accuracy ranging from 25 to 35 % ) [69] . The most promising new 
approach to this problem is the PCR assay. The TB polymerase chain reaction assay (TB 
PCR) on either endoscopic or surgical sections from patients ’ with intestinal tuberculosis 
has been found to have a high accuracy for diagnosing intestinal tuberculosis [59] . This 
test is based on augmenting oligonucleotides found in the M. tuberculosis chromosome 
that are highly specific for the organism, thus increasing its detection rate. PCR assay 
showed a specificity of up to 95 % [5] and an accuracy of 82.6 % for diagnosing 
intestinal tuberculosis [69] . In a study by Pulimood et al which did Mycobacterium 
tuberculosis PCR in mucosal biopsy specimens of 20 patients each of intestinal 
tuberculosis and Crohn’s disease , it was positive in 6 intestinal tuberculosis and 1 
Crohn’s disease specimens [71]. Some studies found no variation in the performance of 
the PCR assay whether the histology showed granuloma or not, and whether granulomas 
showed caseation or not. One of the benefits of using the PCR assay is the speed at which 
the diagnosis can be made. In one study, a definite diagnosis of intestinal tuberculosis 
was concluded in 3 days [72] . 
 
The Tuberculin Skin Test 
 
The PPD skin test has been extensively studied in cases of pulmonary tuberculosis. The 
value of this test is unknown for intestinal tuberculosis, but from these studies we can 
conclude that diagnostic value of this test varies according to the population that is being 
tested. In communities with a moderate to high prevalence of smear positive pulmonary 
tuberculosis  (>20 per 100,000 per year), a positive tuberculin skin test (TST) is more 
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likely to indicate a true tuberculosis infection. However, in areas with a very low 
incidence of active tuberculosis ( < 10 per 100,000 per year), a positive TST will more 
likely be a false positive, and the false-positive rate is very high in areas of the world 
where the bacillus Calmette – Gu é rin (BCG)vaccination is still given [73] . 
Furthermore, anergy in human immunodeficiency virus, primary tuberculosis and 
disseminated tuberculosis further limits the diagnostic utility of this test [74] . Use of 
corticosteroids and immunosuppressive drugs may also limit diagnostic utility of TST. 
 
Quantiferon-Tb Gold 
 
Quantiferon-TB gold (QFT-G) is a blood test that uses an interferon- gamma  -release 
assay that measures the release of interferon after stimulation in vitro by M. tuberculosis 
antigens. The main advantage of this assay with respect to the TST is the lack of cross 
reaction with BCG and most nontuberculous mycobacteria. QFT-G also eliminates 
the need for the patient to return for test reading in 48 – 72 h[75, 76].  It has also been 
used to identify false-positive TSTs  given its high specificity[77, 78].  Most of the 
studies on this test have been performed on pulmonary tuberculosis. Although there is a 
report describing the use of QFT-G in the diagnosis of two cases with intestinal 
tuberculosis [79] , its value has not been formally studied in intestinal tuberculosis. Such 
studies of QFT-G in intestinal tuberculosis are urgently required. 
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Imaging Studies 
 
A chest X-ray shows radiographic features suggestive of tuberculosis in up to 32 % of 
patients with intestinal tuberculosis [80] . A negative chest X-ray does not exclude 
intestinal tuberculosis. Although the intestinal radiographic features of Crohn’s disease 
and intestinal tuberculosis can be similar [69] , there are findings on imaging that can 
help to differentiate them. Barium studies have not been found to be helpful in 
differentiating the two diseases[81].   Computerized tomography scans have become an 
essential tool because it can show the location of the disease, but it also has the advantage 
of evaluating the extent of the inflammatory process and involvement of the intestine, 
mesentery, peritoneum, lymph nodes, solid organs and retroperitoneal disease [82] . In a 
study, asymmetric thickening of the colonic wall and enlarged necrotic lymph nodes were 
highly suggestive of intestinal tuberculosis [83] . In intestinal tuberculosis, the lymph 
nodes were noted to be larger and one-third had necrotic centers. Bowel loop 
displacement was more often due to lymphadenopathy in intestinal tuberculosis, whereas 
in Crohn’s disease it was frequently due to fibrofatty changes. In Crohn’s disease, the 
wall thickening usually is symmetric and concentric and there is mural stratification 
(target sign)[84].  Magnetic resonance imaging is not helpful in discriminating Crohn’s 
disease from intestinal tuberculosis. 
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Endoscopic Features 
 
Endoscopic features of intestinal tuberculosis and Crohn’s disease have a lot of 
similarities, as the mucosal inflammatory response in both disease processes are the same 
[85] . The majority of both intestinal tuberculosis and Crohn’s Disease diseases involve 
the ileo-colonic region, and so ileo-colonoscopy is crucial for the diagnosis of both 
diseases. Rapid diagnosis of intestinal tuberculosis is possible if acid-fast bacilli or 
caseating granulomas are seen on the biopsied tissue. When intestinal tuberculosis affects 
the colon, it can present in different ways, the most common being segmental ulcers and 
colitis, inflammatory strictures or hypertrophic lesions resembling polyps and masses [3, 
45, 64, 86-93]  . Colonic tuberculosis also can present as a diffuse colitis that might 
resemble to a great degree the appearance of ulcerative colitis[15, 45, 86, 90]. In 
tuberculous colitis, the mucosa surrounding an ulcer exhibit feature of inflammation, 
such as erythema, nodularity or edema, but the rectum is rarely involved in intestinal 
tuberculosis [45]. .  Lee et al  in the first systematic prospective analysis evaluated 
endoscopic findings in 44 patients with intestinal tuberculosis and 44 patients with 
Crohn’s Disease.  They  found that anorectal involvement, longitudinal ulcers, aphthous 
ulcers and a cobblestone appearance were all significantly more common in patients with 
Crohn’s disease than in patients with intestinal tuberculosis. In contrast, intestinal 
tuberculosis usually has less than four segments involved, a patulous ileocecal valve, 
transverse ulcers and more scars[6]. Table 1 shows comparison of endoscopic findings 
between Crohn’s disease and intestinal tuberculosis. 
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Table 1. Endoscopic Features of intestinal tuberculosis and Crohn's Disease 
Intestinal tuberculosis Crohn's disease 
Ulcers have circumferential orientation Longitudinal orientation 
Surrounding mucosa inflamed/nodular Surrounding mucosa normal 
Apthous ulcers uncommon Apthous ulcers common 
Hyperaemic nodules-isolated or in clusters Cobblestoning 
Pseudopolyps Multiple skip lesions 
Hypertrophic mucosa Anorectal lesions 
Strictures Strictures 
Destruction of ICV and/or caecum Preservation of ICV 
 
One of the great advantages of endoscopic examination is obtaining biopsy samples, 
which should be taken from ulcer margins. The optimal number of biopsy samples has 
not been established, but one study suggested taking at least 6 samples. Samples should 
be routinely sent for culture. A larger number of biopsies would increase the chance of 
studying granuloma morphology well and identifying Mycobacteria. 
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Pathological Features 
 
Differentiation between intestinal tuberculosis and Crohn’s Disease usually hinges on the 
biopsy specimens obtained at endoscopic examination. Apart from finding acid-fast 
bacilli, which is only found in a fraction of these patients, the differentiation can present a 
great challenge for the pathologist. Pulimood et al identified nine histological parameters 
helpful in distinguishing Crohns disease from intestinal tuberculosis. Features favouring 
intestinal tuberculosis are large granulomas, > four sites of granulomatous inflammation, 
caseation, band of epithelioid histiocytes in ulcer base and granulomatous inflammation 
in caecum.  
Features favouring Crohn’s Disease are non-tuberculous granulomas, mucosal changes 
distant to sites with granulomas, focal crypt-related inflammation, granulomas in sigmoid 
or rectum. 
In a South African study that compared 25 patients with Crohn’s Disease to 18 with 
intestinal tuberculosis, the histological features that were only detected in cases with 
intestinal tuberculosis were confluent granulomata, 10  or more granulomata per biopsy 
site and caseous necrosis. Other features seen in intestinal tuberculosis more often than 
Crohn’s Disease were granulomata exceeding 0.05 mm, ulcers lined by conglomerate 
epithelioid histiocytes and disproportionate submucosal inflammation[8, 10].   
Table 2 shows comparison of histological findings in patients with intestinal tuberculosis 
and Crohn’s disease.  
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Table 2. Prevalence of Selected Histological Parameters in Patients with Intestinal 
Tuberculosis (ITB) and Crohn's Disease (CD): A Comparison of Three Similar 
Studies (values are in %) 
 
Pulimood et al. 
(1999) Southern 
India [8] 
Pulimood et al. 
(2005) Southern 
India [9] 
Kirsch et al. (2006), Cape 
Town, South Africa [10] 
ITB (n = 
20) 
CD (n = 
20) 
ITB (n = 
33) 
CD (n = 
31) 
ITB (n 
= 18) CD (n = 25) 
Caseous necrosis 40 0 36 0 22 0 
Confluent granulomas 60 0 42 3 50 0 
≥5 granulomas/biopsy site 40 0 45 0 44 24 
≥10 granulomas/biopsy site -- -- -- -- 33 0 
Large granulomas Diameter > 200 µm Diameter > 400 µm Area > 0.05 mm2 
90 5 51 0 67 8 
Submucosal granulomas 45 5 39 6 44 12 
Ulcers lined by bands of epithelioid 
histiocytes 
45 5 61 0 61 8 
Disproportionate submucosal 
inflammation 
65 5 -- -- 67 10 
Architectural distortion distant to 
granulomatous inflammation 
-- -- 0 62 -- -- 
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Materials and methods 
Case records of patients with definite diagnosis of  intestinal tuberculosis and Crohn’s 
disease were analysed using uniform structured data forms with respect to clinical, 
laboratory, radiologic, endoscopic and histological parameters.   
 
Inclusion Criteria 
Patients with definite diagnosis of intestinal tuberculosis or Crohn’s disease.  
 
Diagnostic criteria of intestinal tuberculosis  [6]  
Clinical, colonoscopic, and/or radiologic evidence of  intestinal tuberculosis with one 
of the criteria shown below.  
• Histological demonstration of acid fast bacilli.  
• Growth of Mycobacterium  tuberculosis on tissue culture. 
• Histological evidence of caseating granulomas 
• Proved tuberculosis elsewhere in the body. 
• Sustained response to ATT.  
 
Diagnostic criteria of Crohn’s disease [6]   
Positive response to therapy for Crohn’s disease with any  of the two criteria as 
shown  below.  
• Clinical history of chronic diarrhoea, abdominal pain, weight loss, and/or 
rectal bleeding. 
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• Endoscopic findings of mucosal cobblestoning, linear ulceration or skip areas. 
• Radiologic findings of stricture, fistula, mucosal cobblestoning or ulceration. 
• Histological  findings of chronic inflammation/ granulomas. 
• Macroscopic appearance of bowel-wall induration, mesenteric 
lymphadenopathy, and “creeping fat” at laparotomy. 
 
Statistical methods 
 
Sample size was calculated based on the following assumptions.  From the previous 
studies , the prevalence of deep linear ulcer in the Crohn’s disease group was 57% and in 
the intestinal tuberculosis group was 23%[69].  To find a 35% difference in the 
prevalence of deep linear ulcer between  Crohn’s disease and intestinal tuberculosis with 
a power of 80% and 5% level of significance, the sample size was calculated as 56 in 
each group.  
Continuous data is presented as mean with standard deviation and categorical data as 
proportions.  Univariate analysis was done to identify the significantly  different 
characteristics  between the two diseases. The categorical  variables were compared using 
chi square test and the continuous variables using t test. A p value of < 0.05 was taken as 
significant; the significant parameters were included in multivariate analysis using 
logistic  regression method. The data was analyzed using STATA software.  
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Development of scoring system 
 
After logistic regression analysis, each of the regression coefficients of the final 
significant parameters  was multiplied by 10 and rounded off to the nearest integer. A 
total score was calculated for each patient by summing up the individual coefficients 
expressed in integers. The total score was plotted on ROC curve [94]  to derive the cut off 
score to differentiate intestinal tuberculosis from Crohn’s disease . The model was 
validated using bootstrapping method [95]. 
 The bootstrap analysis involves drawing 1000 samples from the original dataset.  For 
each sample, the logistic regression model  is performed using the variables which are 
significant in the univariate analysis.  The number of times each of the final variables 
appear in the repeated models indicates stability or consistency of the variable. If the 
variable in model occurs in more than 50% ( >500)  of the bootstrap samples, then the 
variable in the  final model is considered good.  
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Results 
 
A total of 110 patients with intestinal tuberculosis (ITB) and 103 patients with Crohn’s 
disease (CD) were identified for the study.  In the intestinal tuberculosis group there were 
65 (59.09%) males and 45 (40.91%) females, while in the Crohn’s disease group there 
were 61 (59.22%)  males and 42 (40.78%) females.  
 
The mean age of the patients with intestinal tuberculosis [35.2 + 13.14 years(range 8-66)] 
was similar to the patients with  Crohn’s disease  [33.2 + 12.70 years (range 9-68)].  
 
 
 
Clinical features 
 
 
The frequency of clinical symptoms and signs in patients with intestinal tuberculosis and 
Crohn’s disease are shown in Table 1.  
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   Table 1: Clinical features    
Parameter TB (n=110) CD (n=103) P value 
Blood in stools 17 (15.5) 38 (36.89) <0.001 
Diarrhea 34 (30.91) 55 (53.40) 0.001 
Abdominal pain 97 (88.18) 76 (73.79) 0.007 
Anorexia 58 (52.73) 29 (28.16) <0.001 
Vomiting 58 (52.73) 31 (30.10) 0.001 
Weight loss 81 (73.64) 55 (53.40) 0.002 
Fever 45 (40.91) 36 (34.95) 0.37 
Oral ulcers 4 (3.64) 7 (6.80) 0.30 
Joint symptoms 2 (1.82) 17 (16.50) <0.001 
Mass abdomen 9 (8.18) 6 (4.85) 0.37 
Perianal disease 2 (1.82) 14 (13.59) 0.001 
 
 
Univariate analysis showed that blood in stools (P=<0.001), diarrhea (P=0.001), joint 
symptoms (P=<0.001) and perianal disease (P=0.001) were more common in Crohn’s 
disease  while abdominal pain (P=0.007), anorexia (P=<0.001), vomiting (P=0.001) and 
weight loss (P=0.002) were more often seen  in intestinal tuberculosis .  
The mean duration of symptoms in patients with intestinal tuberculosis [29.5 months 
(range 1-240 ) ] was similar to those with Crohn’s disease [29.37 months (range 1-240 ) ]  
(p= 0.975). 
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Blood tests 
 
ESR, CRP and serum albumin in patients with intestinal tuberculosis and Crohn’s disease  
are shown in Table 2.  
 
Table 2: Blood investigations   
Test TB CD  P value 
Hb 11.4 + 0.9 (n=110) 10.3 + 0.2 (n=98) 0.29 
ESR 69.5 + 11.8 (n=94) 59.9 + 3.3 (n=95) 0.43 
CRP 32.8 + 4.7 (n=45) 37.5 + 4.8 (n=70) 0.50 
Albumin 3.19 + 0.08 (n=99) 3.21 + 0.1 (n=94) 0.85 
 
 
Blood investigations revealed anemia, high ESR, high CRP and low albumin (< 3.5 g/dL) 
in most patients of both groups; there was no significant difference between the two 
groups.  
 
Radiology 
Barium Meal Follow Through (BMFT) 
A total of 35 patients with intestinal tuberculosis and 61 with Crohn’s disease had BMFT. 
Table 3 shows the comparison of BMFT findings between the two groups.  
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Table 3: BMFT findings  
Parameter TB (n=35) CD(n=61) P value 
Segmentation 0 (0) 1 (1.64) 0.45 
Flocculation 0 (0) 1 (1.64) 0.45 
Retraction of mesenteric border 0 (0) 6 (9.84) 0.06 
Antimesenteric sacculations 0 (0) 6 (9.84) 0.06 
Patulous IC valve 1 (2.86) 1 (1.64) 0.69 
Contracted cecum 17 (48.57) 15 (24.59) 0.016 
Cobblestone appearence 0 (0) 6 (9.84) 0.06 
Narrowed IC junction 7 (20.00) 6 (9.84) 0.16 
Short segment stricture 10 (27.78) 9 (14.75) 0.12 
Long segment stricture 0 (0) 5 (8.20) 0.08 
Ulcer 5 (14.29) 11 (17.74) 0.66 
Fistula 1 (2.86) 1 (1.64) 0.69 
Pulled up IC junction 8 (22.86) 4 (6.67) 0.022 
Separated small bowel loops 1 (2.86) 7 (11.67) 0.14 
. 
After univariate analysis, contracted cecum (P= 0.016) and a pulled up IC junction (P= 
0.022) were significantly more common in intestinal tuberculosis as compared to Crohn’s 
disease. 
Retraction of mesenteric border, antimesenteric sacculations, cobblestone appearance and 
long segment stricture were more often seen in Crohn’s disease but did not reach 
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statistical significance probably because of the small number of patients in whom the 
study was performed.   
 
CT abdomen 
CT abdomen was performed on 42 patients with intestinal tuberculosis and 35 patients 
with Crohn’s disease.  The CT abdomen findings are shown in Table 4. 
 
Table 4: CT findings   
Parameter TB(n=42) CD(n=35) P value 
Short segment stricture 11 (26.19) 8 (22.86) 0.74 
Ascites 7 (16.67) 2 (5.71) 0.14 
Omega sign 1 (2.38) 1 (2.86) 0.90 
Fistulae 3 (7.14) 5 (14.29) 0.31 
Mesenteric fat proliferation 2 (4.76) 4 (11.43) 0.28 
Contracted cecum 3 (7.14) 0 (0) 0.11 
Mesenteric hypervascularity (Comb sign) 0 (0) 5 (14.29) 0.011 
Abdominal nodes 31 (73.81) 9 (25.71) <0.001 
Mural thickening 33 (78.57) 26 (74.29) 0.66 
 
Abdominal nodes were found more often in patients with intestinal tuberculosis  (P= < 
0.001) while mesenteric hypervascularity was more common in Crohn’s disease (P= 
0.011). Other parameters evaluated were similar in the two groups of patients. 
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Colonoscopy 
Colonoscopy was performed in all patients included in the study .  The colonoscopy 
findings in patients with intestinal tuberculosis and Crohn’s disease  are shown in  
Table 5. 
Table 5: Colonoscopy findings. 
Parameter TB(n=110) CD(n=103) P value 
Pseudopolyps 4 (3.64) 17 (16.50) 0.002 
Skip lesions 0 (0) 3 (2.91) 0.07 
Cobble stone appearence 1 (0.91) 5 (4.85) 0.08 
Nonulcerated stenosis 21 (19.09) 8 (7.77) 0.016 
Ulcerated stenosis 21 (19.09) 4 (3.88) 0.001 
Aphthous ulcer 3 (2.73) 29 (28.16) <0.001 
Linear/Serpiginous ulcer 1 (0.91) 12 (11.65) 0.001 
Transverse ulcer 2 (1.82) 1 (0.97) 0.60 
Narrowed IC valve 18 (16.36) 4 (3.88) 0.003 
Patulous IC valve 15 (13.64) 9 (8.74) 0.26 
 
Pseudopolyps (p=0.002), aphthous ulcers (p= <0.001) and  linear/ serpiginous ulcers 
(p=0.001) were more common in Crohn’s disease than intestinal tuberculosis while 
nonulcerated stenosis (P= 0.016) , ulcerated stenosis (P= 0.001) and narrowed IC valve 
(P= 0.003 ) were more often seen in patients with intestinal tuberculosis.  
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Histopathology 
Colonoscopy biopsy 
Table 6 shows the histological features on colonoscopy biopsy in the patients studied.   
 
Table 6: Histological features on colonoscopy biopsy   
Parameter TB (n=110) CD(n=103) P value 
Chronic inflammation 92 (83.64) 76 (73.79) 0.08 
Ulceration 52 (47.27) 26 (25.24) 0.001 
Granulomas 57 (51.82) 31 (30.1.) 0.001 
Confluent granulomas 27 (24.55) 2 (1.94) <0.001 
Cryptitis 39 (35.45) 46 (44.66) 0.17 
Crypt abscess 28 (25.45) 29 (28.16) 0.66 
Architectural alteration 19 (17.27) 19 (18.45) 0.82 
 
Table 6 shows that ulceration (P= 0.001), granulomas (P= 0.001) and confluent 
granulomas (p= <0.001) were more common in intestinal tuberculosis than Crohn’s 
disease.     
Development of the scoring system 
Table 7 shows the clinical, colonoscopy and histopathology parameters that were 
significantly different in intestinal tuberculosis and Crohn’s disease after univariate 
analysis. 
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Table 7:Parameters that were significantly different in intestinal tuberculosis and 
Crohn’s disease after univariate analysis. 
Parameter TB CD  P value 
Blood in stools 17 (15.5) 38 (36.89) <0.001 
Diarrhea 34 (30.91) 55 (53.40) 0.001 
Abdominal pain 97 (88.18) 76 (73.79) 0.007 
Anorexia 58 (52.73) 29 (28.16) <0.001 
Vomiting 58 (52.73) 31 (30.10) 0.001 
Weight loss 81 (73.64) 55 (53.40) 0.002 
Joint symptoms 2 (1.82) 17 (16.50) <0.001 
Perianal disease 2 (1.82) 14 (13.59) 0.001 
Pseudopolyps 4 (3.64) 17 (16.50) 0.002 
Nonulcerated stenosis 21 (19.09) 8 (7.77) 0.016 
Ulcerated stenosis 21 (19.09) 4 (3.88) 0.001 
Aphthous ulcer 3 (2.73) 29 (28.16) <0.001 
Linear/Serpiginous ulcer 1 (0.91) 12 (11.65) 0.001 
Narrowed IC valve 18 (16.36) 4 (3.88) 0.003 
Ulceration 52 (47.27) 26 (25.24) 0.001 
Granulomas 57 (51.82) 31 (30.1.) 0.001 
Confluent granulomas 27 (24.55) 2 (1.94) <0.001 
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After univariate analysis the parameters that were significantly more common in 
intestinal tuberculosis  were:   
(a) Clinical :  abdominal pain, anorexia, vomiting, weight loss.   
(b) Colonoscopy: nonulcerated / ulcerated stenosis, narrowed IC valve.    
(c) Histology:  ulceration, granulomas,  confluent granulomas.  
Parameters significantly more common in Crohn’s disease were:  
(a) Clinical: blood in stools, diarrhea, joint symptoms, perianal disease   
(b) Colonoscopy: pseudopolyps, aphthous ulcers and linear/ serpiginous ulcers.  
 
The blood tests and radiology parameters were not included in multivariate analysis since 
the data was incomplete for those parameters.  
 
Logistic regression was then performed using the parameters that were significant on 
univariate analysis. The results of logistic regression analysis is shown in Table 8. 
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Table 8: Parameters that were significantly different in intestinal tuberculosis and 
Crohn’s disease after logistic regression analysis.  
Parameter Coefficient P value 
Anorexia 1.104188    0.020      
Vomiting 0.8633479    0.042 
Pseudopolyps -1.869838    0.023     
Aphthous ulcer -2.456286    0.003     
Linear/Serpiginous ulcer -3.522889    0.031 
Ulceration 1.426832    0.002      
Confluent granulomas 4.272531    <0.001 
 
After logistic regression analysis the  parameters that favoured intestinal tuberculosis 
were : 
Clinical : Anorexia ,vomiting.  
Histology: Ulceration ,confluent granulomas. 
The parameters that favoured Crohn’s disease were : 
Colonoscopy: pseudopolyps, aphthous ulcers, linear / serpiginous ulcers 
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Each of the coefficients  of the significant parameters after logistic regression analysis 
was  multiplied by 10 and rounded off to the nearest integer to obtain a score for each 
parameter- (Table 9) 
Table 9: Score of individual parameter 
Parameter Coefficient Score 
Anorexia 1.104188    +11    
Vomiting 0.8633479    +9 
Pseudopolyps -1.869838    -19     
Aphthous ulcer -2.456286    -25     
Linear/Serpiginous ulcer -3.522889    -35 
Ulceration 1.426832    +14      
Confluent granulomas 4.272531    +43 
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A total score was calculated for each patient by summing up the individual coefficients 
expressed in integers. The total score was plotted on ROC curve to derive the cut-points. 
(Figure 1). 
 
 
 
 
Figure 1: ROC curve  
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The detailed report of sensitivity and specificity is shown in Table 10.  
Table 10. 
 
Detailed report of Sensitivity and Specificity 
------------------------------------------------------------------------------ 
                                           Correctly 
Cutpoint      Sensitivity   Specificity   Classified          LR+          LR- 
------------------------------------------------------------------------------ 
( >= -65 )        100.00%         0.00%       51.64%       1.0000      
( >= -54 )        100.00%         0.97%       52.11%       1.0098       0.0000 
( >= -49 )        100.00%         2.91%       53.05%       1.0300       0.0000 
( >= -46 )        100.00%         3.88%       53.52%       1.0404       0.0000 
( >= -37 )        100.00%         5.83%       54.46%       1.0619       0.0000 
( >= -25 )        100.00%         6.80%       54.93%       1.0729       0.0000 
( >= -24 )        100.00%        15.53%       59.15%       1.1839       0.0000 
( >= -21 )        100.00%        17.48%       60.09%       1.2118       0.0000 
( >= -19 )        100.00%        19.42%       61.03%       1.2410       0.0000 
( >= -16 )        100.00%        23.30%       62.91%       1.3038       0.0000 
( >= -14 )        100.00%        28.16%       65.26%       1.3919       0.0000 
( >= -11 )         99.09%        29.13%       65.26%       1.3981       0.0312 
( >= -10 )         99.09%        30.10%       65.73%       1.4176       0.0302 
( >= -8 )          99.09%        34.95%       68.08%       1.5233       0.0260 
( >= -5 )          98.18%        35.92%       68.08%       1.5322       0.0506 
( >= 0 )           98.18%        39.81%       69.95%       1.6311       0.0457 
( >= 1 )           90.00%        67.96%       79.34%       2.8091       0.1471 
( >= 6 )           89.09%        67.96%       78.87%       2.7807       0.1605 
( >= 8 )           89.09%        68.93%       79.34%       2.8676       0.1583 
( >= 9 )           89.09%        69.90%       79.81%       2.9601       0.1561 
( >= 11 )          76.36%        79.61%       77.93%       3.7455       0.2969 
( >= 14 )          70.91%        85.44%       77.93%       4.8691       0.3405 
( >= 15 )          62.73%        89.32%       75.59%       5.8736       0.4173 
( >= 17 )          61.82%        89.32%       75.12%       5.7884       0.4275 
( >= 18 )          60.91%        89.32%       74.65%       5.7033       0.4376 
( >= 20 )          60.00%        89.32%       74.18%       5.6182       0.4478 
( >= 23 )          48.18%        96.12%       71.36%      12.4068       0.5391 
( >= 24 )          41.82%        97.09%       68.54%      14.3576       0.5993 
( >= 25 )          40.91%        97.09%       68.08%      14.0455       0.6086 
( >= 34 )          32.73%        98.06%       64.32%      16.8545       0.6860 
( >= 43 )          21.82%        99.03%       59.15%      22.4726       0.7895 
( >= 52 )          20.00%        99.03%       58.22%      20.5999       0.8078 
( >= 54 )          18.18%        99.03%       57.28%      18.7272       0.8262 
( >= 57 )          12.73%        99.03%       54.46%      13.1090       0.8813 
( >= 63 )           9.09%       100.00%       53.05%                    0.9091 
( >= 66 )           8.18%       100.00%       52.58%                    0.9182 
( >= 68 )           5.45%       100.00%       51.17%                    0.9455 
( >= 77 )           2.73%       100.00%       49.77%                    0.9727 
( >  77 )           0.00%       100.00%       48.36%                    1.0000 
------------------------------------------------------------------------------ 
 
 
                      ROC                    -Asymptotic Normal-- 
           Obs       Area     Std. Err.      [95% Conf. Interval] 
         -------------------------------------------------------- 
           213     0.8764       0.0229        0.83163     0.92124 
       number of observations =         213 
      Hosmer-Lemeshow chi2(3) =         2.06 
                  Prob > chi2 =         0.5610 
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Table 10 shows that a ‘cut off score’ of  +11 ( >/=  +11 favours intestinal tuberculosis  
and < +11 favours Crohn’s disease)  has a sensitivity of 76.36% and a specificity of 
79.61% in differentiating intestinal tuberculosis from Crohn’s disease.  The model was 
validated using bootstrap analysis. The result of boot strap analysis is shown in Table 11.  
All variables selected after logistic regression analysis occurred in > 50% of the bootstrap 
samples confirming the validity of the variables.  
 
Table 11: Number of times each variable was selected on bootstrapping.  
Parameter No: of times each variable 
was selected 
Anorexia 810 
Vomiting 700 
Pseudopolyps 750 
Aphthous ulcer 870 
Linear/Serpiginous ulcer 530 
Ulceration 930 
Confluent granulomas 760 
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Discussion 
Differentiating Crohn’s disease from intestinal tuberculosis is of utmost importance 
because treatment for the two diseases are  different and wrong treatment may result in 
disastrous consequences.   Earlier studies have attempted to identify parameters on 
clinical , radiologic or endoscopic / histological evaluation to differentiate the two 
diseases.  Unfortunately , the dilemma of differentiating the two diseases which have 
similar presentations still continues. The present study was therefore aimed at 
comprehensively studying  the problem, identifying parameters that differentiate 
intestinal tuberculosis  from Crohn’s disease and develop a scoring system to make a 
positive diagnosis.  
Previous studies have identified clinical features that are more common either in 
intestinal tuberculosis  or Crohn’s disease.  Amarapurkar et al have reported absence of 
fever, presence of hematochezia, presence of diarrhoea and long duration of symptoms to 
be more common in Crohn’s disease than intestinal tuberculosis [69].  Another study by 
Makharia et al found blood in stools to be more common in Crohn’s disease  and weight 
loss more common in intestinal tuberculosis[68].  A study from China did not find any 
significant difference  in the clinical features between the two diseases [58].  In the 
present study  there was no difference between the two groups with respect to age or sex 
of the individual or the duration of the disease.     
Univariate analysis of  clinical features showed that blood in stools, diarrhea, joint 
symptoms and perianal disease were  more common among the  patients with Crohn’s 
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disease  whereas abdominal pain, anorexia, vomiting and  weight loss were found to be 
more common among the patients with  intestinal tuberculosis. After logistic regression 
analysis anorexia and vomiting were significant and both favoured intestinal tuberculosis.   
 
Blood investigations have not been helpful in differentiating the two diseases in previous 
studies though anemia has been found to be more prevalent in Crohn’s disease than 
intestinal tuberculosis [69]. In our study , the results of  Hb, ESR, CRP and albumin  
between the two groups were comparable.  
 
Barium studies have not been found to be helpful in differentiating the two diseases. In a 
study of 36 patients by Makanjuola et al, none of the BMFT findings could differentiate 
between intestinal tuberculosis and  Crohn’s disease [81].   In the present study,  35 
patients with intestinal tuberculosis and 61 patients with Crohn’s disease had BMFT 
done.  Contracted cecum and pulled up ic junction were found to be more common in 
intestinal tuberculosis than Crohn’s disease . However these parameters were not 
included in logistic regression analysis since the data was not available for all the 
patients.  
Boudiaf et al have shown that CT parameters which help differentiate between the two 
diseases are abdominal nodes and bowel wall thickening which favour intestinal 
tuberculosis and mesenteric hypervascularity which favours Crohn’s disease [83]. In the 
present study, where 42 patients with intestinal tuberculosis and 35 patients with Crohn’s 
disease had CT abdomen done,  mesenteric hypervascularity ( comb sign) was noted to 
favour Crohn’s disease and abdominal nodes were noted to be more common in intestinal 
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tuerculosis. .   Bowel wall thickening was however comparable between the two groups. 
Logistic regression analysis could not be done on these variables since the data was 
incomplete.  
 
Attempts have been made in the past to identify colonoscopic features which will help to 
differentiate between the two diseases. A study by Lee et al showed anorectal lesions, 
longitudinal ulcers, aphthous ulcers, and cobblestone appearance to be  significantly more 
common  in patients with Crohn’s disease  and  a patulous ileocecal valve, transverse 
ulcers, and pseudopolyps to be  more frequent in patients with intestinal tuberculosis[6].  
Amarapurkar et al showed  linear / serpiginous ulcers and cobble stone appearance to be 
more common in Crohn’s disease compared to intestinal tuberculosis [69]. Aphthous 
ulcers,  linear ulcers and cobble stone appearance were the features favouring Crohn’s 
disease in a study by Makharia et al [68]. In our study, colonoscopy showed 
pseudopolyps, aphthous ulcers, linear/ serpigenous ulcers to be more common in Crohn’s 
disease where as ulcerated stenosis, nonulcerated stenosis and narrowed ic valve were 
more common in intestinal tuberculosis.  Cobble stone appearance was more common in 
Crohn’s disease but the difference was not statistically significant.  On multivariate 
analysis the significant parameters which favoured Crohn’s disease were  pseudo polyps,  
aphthous   ulcers and serpigenous / linear ulcers.  Colonoscopy findings in the present 
study was grossly similar to the previous studies.  
 
Previous studies have shown that  histopathologic findings are helpful in differentiating 
Crohn’s disease from intestinal tuberculosis. Pulimood et al  have reported that on 
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mucosal biopsy, in addition to AFB detection, large granuloma, greater than  four sites of 
granulomatous inflammation, caseation, band of epitheloid histiocytes in ulcer base and 
granulomatous inflammation in cecum favour diagnosis of tuberculosis; whereas non-
caseating granuloma, mucosal changes distant to sites with granuloma, focal crypt-related 
inflammation and granuloma in sigmoid or rectum favour  diagnosis of Crohn’s disease 
[9].   Amarapurkar et al found confluent granulomas to be more prevalent in intestinal 
tuberculosis.    A South African study  and a Chinese study have  also noted confluent 
granulomas to be more common in intestinal tuberculosis[10, 59]  . However in the 
Chinese study it was also reported that apart from caseation and confluent granulomas, no 
other features were helpful in differentiating between the two diseases [59].  Focally 
enhanced colitis was found to be a histological hallmark in making a diagnosis of 
Crohn’s disease in the study by Makharia et al [68].  In our study,  ulceration, granulomas 
and confluent granulomas were more common in intestinal tuberculosis where as the 
other parameters were comparable between the two groups.    After logistic regression 
analysis,  ulceration and confluent granulomas were still found to be significant. 
Limitations of this study were retrospective design and incomplete radiological data. This 
study shows that there are clinical , colonoscopic and histological parameters that are 
different in the two diseases. Further,  all parameters donot have the same weightage.  In 
order to include all parameters and apportion appropriate weightage to each parameter we 
developed a scoring system and hoped that this would help in better differentiating 
intestinal tuberculosis  from Crohn’s disease. For the development of the scoring system,  
the clinical features, colonoscopy findings and the histopathologic findings significant 
after univariate analysis were  included in logistic regression  analysis.  After logistic 
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regression analysis a scoring system was developed as described in the results section.  A 
score of  +11 was derived as the ‘cut off score’ to differentiate between the two diseases.   
A score   >/=  +11 suggested  intestinal tuberculosis and a score of  < +11 suggested  
Crohn’s disease. The scoring system was validated using boot strapping method. A 
prospective study using the scoring system will help confirm and validate its usefulness 
in differentiating intestinal tuberculosis from Crohn’s disease.  
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Conclusion 
 
Evaluation of clinical, radiological, colonoscopic and histological parmeters were 
performed to differentiate intestinal tuberculosis from Crohn’s disease.  
1) On univariate analysis-  
      *Parameters favouring intestinal tuberculosis were -- 
¾ Clinical:            abdominal pain, anorexia, vomiting and weight loss. 
¾ Radiology:        contracted cecum, pulled up IC junction in BMFT and   
                                abdominal nodes in CT abdomen.  
¾ Colonoscopy:    Nonulcerated / ulcerated stenosis, narrowed IC valve. 
¾ Histology:          ulceration, granulomas and confluent granuloma. 
             *Parameters favouring Crohn’s disease were  
¾ Clinical:            blood in stools, diarrhea, joint symptoms and perianal    
                                     disease.  
¾ Radiology:       mesenteric hypervascularity in CT abdomen.  
¾ Colonoscopy:   Pseudopolyps, aphthous ulcer, linear/ serpiginous ulcer. 
¾ Histology:         none  
 
     2)   On multivariate analysis (logistic regression)- 
           * Parameters favouring intestinal tuberculosis were anorexia, vomiting and     
               ulceration and confluent granulomas in histology.  
*Parameters favouring Crohn’s disease were  pseudopolyps ,aphthous ulcers and       
   linear/ serpiginous ulcers in colonoscopy. 
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     3) A scoring system was devised to differentiate intestinal tuberculosis from Crohn’s 
disease. A cut off score >/= +11 was suggestive of intestinal tuberculosis  while a 
score < +11 was suggestive of Crohn’s disease. The model was validated using 
bootstrapping method 
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Proforma 
 
• Serial number 
• DIAGNOSIS: TB / CD  
• Name 
• Age 
• Hospital number 
• Sex 
• Religion 
• Occupation 
• Address 
• E mail 
• Phone number 
History of illness 
 
• Duration of symptoms       
 
• Blood in the stools -yes / no / not recorded 
• Large volume bleed  y / n / nr 
  Transfusions  y / n / nr 
  Hospital admission y / n / nr 
  Surgery  y / n / nr 
 
• Diarrhoea   -y / n / nr 
-Number of times a day 
     -Day 
     -Night 
 
• Abdominal pain -y / n / nr 
    -constant / colicky / other type (description) 
• Subac  obstrn  y / n / nr 
• Anorexia  y / n / nr 
• Vomiting  y / n / nr 
• Wt loss   y / n / nr  
-in kgs 
    -as % 
• Abdominal lump y / n / nr 
• Surgery  y / n / nr 
                
Indication        -For bleeding / obstruction / abscess / perforation / mass /        
                         diagnostic lap  
    -Other indications (description) 
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• Appendicectomy y / n / nr 
• Fever   y / n / nr 
  Character      -Chills / rigors / nr 
        -Continuous / remittent / intermittent / nr 
        - Low grade < 101 F / high grade 101 F or more 
     - Evening rise   y / n / nr (pt feels more fever b/w 4pm and MN) 
     - Is the fever > 101 F, in the absence of an intra abdominal                  
        abscess  y / n / nr 
• Hypercoagulable state 
             Venous thrombosis y / n / nr 
   (if yes, description of vessels involved) 
• Red eye      y / n / nr  
• Skin lesions   y / n / nr       
• Oral ulcers   y / n / nr   
• Joint pains  y / n / nr  
• Joint swellings  y / n / nr 
                         -Which joint 
 
Past history 
 
• Of  TB    -y / n / nr 
                -(if yes, details) 
• Treatment with ATT  y / n / nr 
Details 
• Of BCG   y / n / nr 
Family history 
• TB    y / n / nr (details) 
• CD    y / n / nr (details) 
Physical findings 
• Clubbing   y / n / nr   
• Icterus    y / n / nr 
• Growth retardation  y / n / nr 
• Delayed secondary sexual characteristics  y / n / nr 
• Height   in kgs  
• Weight  in cms 
• BMI 
• Hepatomegaly  y / n / nr 
• Splenomegaly  y / n / nr 
• Mass    -y / n / nr 
      -If yes, location 
• Peristalsis  y / n / nr 
• Ascites  y / n / nr 
• Nodes    -y / n / nr 
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-site    
     -size    
-character   
• Perianal disease -y / n / nr  (current or evidence of past disease) 
-Fissure  y / n / nr 
-Fistula  y / n / nr 
-Abscess  y / n / nr 
• Extraintestinal manifestations 
-Pyoderma y / n / nr 
               -E nodosum      y / n / nr 
    -Vasculitis y / n / nr 
    -Oral ulcers y / n / nr 
    -A spondylitis y / n / nr 
    -Arthritis y / n / nr     
                                                     Which joint: 
    -Episcleritis y / n / nr 
    -Uveitis y / n / nr 
 
BMFT 
• Not done 
• Normal                                  y / n / nr 
• Stricture   y / n / nr 
• Ulcer    y / n / nr 
• Fistula    y / n / nr 
• mucosal fold thickening y / n / nr 
• intermediary segments y / n / nr 
• segmentation 
• flocculation 
• skip lesions 
• retraction of mesenteric border 
• antmesenteric sacculations 
• Patulous ic valve 
• Narrowed ic junction 
• contracted cecum 
• cobble stoning 
• pulled up cecum 
• separated small bowel loops 
•  
CT  
• not done    y / n / nr 
• Normal    y / n / nr 
• Stricture    y / n / nr 
• inflammatory mass   y / n / nr 
• Ascites    y / n / nr 
• Ascites when albumin > 2.5  y / n / nr 
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• Peritoneal thickening   y / n / nr 
• Mesenteric thickening   y / n / nr 
• Mesenteric fat proliferation  y / n / nr 
• Contracted cecum   y / n / nr 
• mural thickening   y / n / nr 
• Omega sign    y / n / nr 
• Internal fistulae    y / n / nr 
• Omental cake    y / n / nr 
• Cocoon    y / n / nr 
• Creeping fat    y / n / nr 
• Comb sign     y / n / nr 
• Tuberculoma in liver / spleen  y / n / nr 
• Abdominal nodes   -y / n / nr 
      -Size of nodes / largest 
      -Character   y / n / nr 
      -Matting   y / n / nr 
      -Calcification   y / n / nr 
      -Other descriptions 
 
Upper GI Scopy: 
• Notdone    
• Normal 
• superficial/deep ulcer  y / n / nr 
• aphthous ulcer   y / n / nr 
• Stenosis   y / n / nr 
• gastric erythema  y / n / nr 
• edematous gastric mucosa y / n / nr 
• erosions   y / n / nr 
Lower GI Scopy: 
• not done  
• Normal  
• Ulcerated stenosis  y / n / nr 
•  Non-ulcerated stenosis,  y / n / nr 
• Aphthous ulcers  y / n / nr 
• Pseudopolyps   y / n / nr 
• Linear ulcers/serpigenous y / n / nr 
• Transverse ulcer  y / n / nr 
• Circumferential ulcers y / n / nr 
• only ileal ulcers  y / n / nr 
•  ileo-colonic ulcers  y / n / nr 
• Cobblestoning   y / n / nr 
• Fistula    y / n / nr 
• Skip lesions   y / n / nr 
• Neoplasm like appearance y / n / nr 
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• Contracted cecum  y / n / nr 
• Narrowed IC valve  y / n / nr 
• Patulous IC valve  y / n / nr 
Capsule 
• not done 
• Normal 
• SB Ulcers  y / n / nr  
• Stricture  y / n / nr 
• Strictures + Ulcer) y / n / nr 
Surgical findings 
• Skip lesions  y / n / nr 
• Stricutre   -y / n / nr 
-Number of strictures 
-Stricture sites 
-Length of longest stricture (actual length) 
 
• Bowel wall induration             y / n / nr 
• Creeping fat               y / n / nr 
• Mesenteric lymphadenopathy  y / n / nr 
Other Investigations 
 
• Quantiferon gold y / n / nr  
       Result   pos / neg / equivocal / nr 
       Value 
• Mantoux  pos / neg / equivocal / not done 
      Size of the induration 
• CXR   normal / abnormal 
                                          (if abnormal, description) 
• Antibodies 
      ASCA   pos / neg / equivocal / not done 
ANCA   pos / neg / equivocal / not done 
AFB c/s  pos / neg / not done  
TB at extraintestinal site  y /n /nr   ---- Details  
Histology 
Upper GI 
• Chronic inflammation 
• Ulceration 
• Granulomas 
• Confluent granulomas 
• Caseation 
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• Presence of AFB 
• Architectural alteration 
LowerGI 
• Chronic inflammation 
• Ulceration 
• Granulomas 
• Confluent granulomas 
• Caseation 
• Presence of AFB 
• Cryptitis 
• Cyypt abscess 
• Architectural alteration 
Resection specimen histopathology 
• not done 
• Normal 
• chronic inflammation with architecture changes 
• granulomatous inflammation 
• transmural inflammation 
 
Site of disease 
Course 
• Treatment given ATT / ASA / steroids / immunosuppressants (details) 
• If ATT was given 
-Drugs used 
-Duration of treatment 
-? DOTS 
• Reassessment at ______ months 
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OBJECTIVES: (1)To analyze clinical, laboratory, radiologic, endoscopic and histological 
characteristics of intestinal tuberculosis and Crohn’s disease and identify the parameters that 
differentiate the two diseases. (2) To devise and validate a scoring system to help differentiate 
Crohn’s disease from intestinal tuberculosis   
  
METHODS: Case records of patients with definite diagnosis of  intestinal tuberculosis 
and Crohn’s disease were analysed using uniform structured data forms with respect to 
clinical, laboratory, radiologic, endoscopic and histological parameters. Univariate 
analysis to identify the significant differences between the two diseases  was initially 
performed followed by logistic regression analysis to identify the final significant 
parameters. Using  the final significant parameters a scoring system was developed to 
differentiate Crohn’s disease from intestinal tuberculosis. The scoring system was 
validated using  bootstrapping method. 
 
 
RESULTS: Parameters favouring intestinal tuberculosis were anorexia, vomiting and   
ulceration and confluent granulomas in histology. Parameters favouring Crohn’s disease 
were  pseudopolyps ,aphthous ulcers and  linear/ serpiginous ulcers in colonoscopy.  A 
scoring system was devised to differentiate intestinal tuberculosis from Crohn’s disease. 
A cut off score >/= +11 was suggestive of intestinal tuberculosis  while a score < +11 
was suggestive of Crohn’s disease. The model was validated using bootstrapping method 
 
